Stoke Therapeutics (STOK) Other Gross PP&E Adjustments (2022 - 2025)
Stoke Therapeutics (STOK) has 4 years of Other Gross PP&E Adjustments data on record, last reported at -$5.4 million in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 18.51% year-over-year to -$5.4 million; the TTM value through Sep 2025 reached -$5.4 million, up 18.51%, while the annual FY2024 figure was $7.3 million, 5.67% down from the prior year.
- Other Gross PP&E Adjustments reached -$5.4 million in Q3 2025 per STOK's latest filing, down from -$4.3 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $7.7 million in Q4 2023 and bottomed at -$7.8 million in Q1 2024.
- Average Other Gross PP&E Adjustments over 4 years is -$3.2 million, with a median of -$5.3 million recorded in 2025.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 82.83% in 2024, then soared 44.21% in 2025.
- A 4-year view of Other Gross PP&E Adjustments shows it stood at $5.6 million in 2022, then surged by 38.17% to $7.7 million in 2023, then decreased by 5.67% to $7.3 million in 2024, then crashed by 173.66% to -$5.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$5.4 million in Q3 2025, -$4.3 million in Q2 2025, and -$5.3 million in Q1 2025.